Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10699
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDimopoulos, Nektariaen
dc.contributor.authorJackson, Heather Men
dc.contributor.authorEbert, Lisaen
dc.contributor.authorGuillaume, Philippeen
dc.contributor.authorLuescher, Immanuel Fen
dc.contributor.authorRitter, Gerden
dc.contributor.authorChen, Weisanen
dc.date.accessioned2015-05-16T00:14:05Z
dc.date.available2015-05-16T00:14:05Z
dc.date.issued2008-10-26en
dc.identifier.citationJournal of Immunological Methods 2008; 340(1): 90-4en
dc.identifier.govdoc18957296en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10699en
dc.description.abstractAs more tumor antigens are discovered and as computer-guided T cell epitope prediction programs become more sophisticated, many potential T cell epitopes are synthesized and demonstrated to be antigenic in vitro. However, it is estimated that about 50% of such tumor antigen-specific T cells have not been demonstrated to recognize the naturally presented epitopes due to either technical difficulties, such as T cell cloning which is still challenging for many laboratories; or the predicted T cell epitopes are not generated or not generated in sufficient amounts by the antigen processing machinery. However, to potentially identify clinically relevant vaccine candidate epitopes, it is essential to demonstrate natural antigen presentation. Here we combine the advantages of MHC tetramer and intracellular cytokine staining to sensitively detect natural antigen presentation by tumor cells for epitopes of interest. The novel method does not require T cell cloning or long-term T cell culture. Because the antigen-specific T cells are positively identified, this method is much less influenced by IFNgamma producing cells with unknown specificities and should be widely applicable.en
dc.language.isoenen
dc.subject.otherAntigens, Neoplasm.analysis.immunologyen
dc.subject.otherCD8-Positive T-Lymphocytes.immunologyen
dc.subject.otherCell Line, Tumoren
dc.subject.otherCytokines.analysis.immunologyen
dc.subject.otherEpitopes, T-Lymphocyte.analysis.immunologyen
dc.subject.otherFlow Cytometryen
dc.subject.otherHistocompatibility Antigens.immunologyen
dc.subject.otherHumansen
dc.subject.otherMelanoma.immunologyen
dc.titleCombining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of immunological methodsen
dc.identifier.affiliationLudwig Institute for Cancer Research, Melbourne Branch, Austin Health, Heidelberg, VIC 3084, Australiaen
dc.identifier.doi10.1016/j.jim.2008.09.023en
dc.description.pages90-4en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/18957296en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.